MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility-based providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment.
Industry, Sector and Symbol
Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
Phone615-627-4710
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$61.10 million
Profitability
Miscellaneous
Employees12
Next Earnings DateN/A
OptionableNot Optionable
MedEquities Realty Trust (NYSE:MRT) Frequently Asked Questions
What is MedEquities Realty Trust's stock symbol?
MedEquities Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MRT."
How often does MedEquities Realty Trust pay dividends? What is the dividend yield for MedEquities Realty Trust?
MedEquities Realty Trust announced a quarterly dividend on Thursday, August 2nd. Investors of record on Wednesday, August 15th will be given a dividend of $0.21 per share on Wednesday, August 29th. This represents a $0.84 annualized dividend and a dividend yield of 7.82%. The ex-dividend date of this dividend is Tuesday, August 14th. View MedEquities Realty Trust's Dividend History.
How were MedEquities Realty Trust's earnings last quarter?
MedEquities Realty Trust Inc (NYSE:MRT) posted its quarterly earnings results on Wednesday, August, 8th. The financial services provider reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.30 by $0.20. The financial services provider had revenue of $17.56 million for the quarter, compared to analysts' expectations of $17.03 million. MedEquities Realty Trust had a return on equity of 3.39% and a net margin of 19.98%. View MedEquities Realty Trust's Earnings History.
What price target have analysts set for MRT?
9 analysts have issued twelve-month price objectives for MedEquities Realty Trust's shares. Their forecasts range from $9.00 to $12.00. On average, they expect MedEquities Realty Trust's share price to reach $10.6250 in the next year. This suggests that the stock has a possible downside of 1.1%. View Analyst Price Targets for MedEquities Realty Trust.
What is the consensus analysts' recommendation for MedEquities Realty Trust?
9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MedEquities Realty Trust in the last year. There are currently 8 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MedEquities Realty Trust.
Has MedEquities Realty Trust been receiving favorable news coverage?
News stories about MRT stock have trended positive recently, InfoTrie reports. InfoTrie ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. MedEquities Realty Trust earned a daily sentiment score of 2.7 on InfoTrie's scale. They also gave news articles about the financial services provider a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near term.
Who are some of MedEquities Realty Trust's key competitors?
Some companies that are related to MedEquities Realty Trust include Kite Realty Group Trust (KRG), TPG RE Finance Trust (TRTX), TIER REIT (TIER), Redwood Trust (RWT), Saul Centers (BFS), Monmouth R.E. Inv. (MNR), Summit Hotel Properties (INN), PennyMac Mortgage Investment Trust (PMT), American Finance Trust (AFIN), KKR Real Estate Finance Trust (KREF), ARBOR RLTY TR I/SH (ABR), Interrent Real Estate Investment Trust (IIPZF), Easterly Government Properties (DEA), Ramco-Gershenson Properties Trust (RPT) and Washington Prime Group (WPG).
What other stocks do shareholders of MedEquities Realty Trust own?
Who are MedEquities Realty Trust's key executives?
MedEquities Realty Trust's management team includes the folowing people:
- Mr. John W. McRoberts, Chairman & CEO (Age 66)
- Mr. William C. Harlan, Pres, COO & Director (Age 67)
- Mr. Jeffery C. Walraven, Exec. VP, CFO, Sec. & Treasurer (Age 49)
- Mr. David Louis Travis, Sr. VP & Chief Accounting Officer (Age 44)
- Mr. Tripp Sullivan, Investor Relations, SCR Partners, LLC
When did MedEquities Realty Trust IPO?
(MRT) raised $259 million in an initial public offering on Thursday, September 29th 2016. The company issued 19,900,000 shares at $12.00-$14.00 per share. FBR, J.P. Morgan, Citigroup, KeyBanc Capital Markets, Raymond James and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities, Fifth Third Securities and Capital One Securities were co-managers.
Who are MedEquities Realty Trust's major shareholders?
MedEquities Realty Trust's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Prudential Financial Inc. (8.17%), BlackRock Inc. (5.54%), Nuveen Asset Management LLC (3.88%), Bank of New York Mellon Corp (1.31%), Geode Capital Management LLC (1.07%) and Dimensional Fund Advisors LP (0.45%). Company insiders that own MedEquities Realty Trust stock include Bluemountain Capital Managemen, John W Mcroberts, Randy L Churchey and William C Harlan. View Institutional Ownership Trends for MedEquities Realty Trust.
Which major investors are selling MedEquities Realty Trust stock?
MRT stock was sold by a variety of institutional investors in the last quarter, including Martingale Asset Management L P, Nuveen Asset Management LLC, Bank of New York Mellon Corp, LSV Asset Management, Raymond James & Associates, Bessemer Group Inc., Janney Montgomery Scott LLC and Citigroup Inc.. View Insider Buying and Selling for MedEquities Realty Trust.
Which major investors are buying MedEquities Realty Trust stock?
MRT stock was purchased by a variety of institutional investors in the last quarter, including Prudential Financial Inc., D. E. Shaw & Co. Inc., BlackRock Inc., Raymond James Financial Services Advisors Inc., Dimensional Fund Advisors LP, Two Sigma Investments LP, Geode Capital Management LLC and California Public Employees Retirement System. Company insiders that have bought MedEquities Realty Trust stock in the last two years include John W Mcroberts, Randy L Churchey and William C Harlan. View Insider Buying and Selling for MedEquities Realty Trust.
How do I buy shares of MedEquities Realty Trust?
Shares of MRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is MedEquities Realty Trust's stock price today?
One share of MRT stock can currently be purchased for approximately $10.74.
How big of a company is MedEquities Realty Trust?
MedEquities Realty Trust has a market capitalization of $342.21 million and generates $61.10 million in revenue each year. The financial services provider earns $20.42 million in net income (profit) each year or $1.14 on an earnings per share basis. MedEquities Realty Trust employs 12 workers across the globe.
What is MedEquities Realty Trust's official website?
How can I contact MedEquities Realty Trust?
MedEquities Realty Trust's mailing address is 3100 WEST END AVENUE SUITE 1000, NASHVILLE TN, 37203. The financial services provider can be reached via phone at 615-627-4710 or via email at [email protected]
MarketBeat Community Rating for MedEquities Realty Trust (NYSE MRT)
MarketBeat's community ratings are surveys of what our community members think about MedEquities Realty Trust and other stocks. Vote "Outperform" if you believe MRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
